Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin

被引：24
|
作者：
de Zwaan, Sally E. [3 ]
Iland, Harry J. [1 ]
Damian, Diona L. [2 ,3 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Haematol, Sydney, NSW, Australia
[2] Univ Sydney, Dept Dermatol, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Dermatol, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2009年 / 50卷 / 01期
关键词：
corticosteroid adverse effects; diabetes mellitus; imatinib mesylate;
D O I：
10.1111/j.1440-0960.2008.00506.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.
引用
收藏
页码：56 / 59
页数：4
相关论文
共 50 条
  • [31] A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy
    ZHANG Xibao HE Yuqing ZHOU Hua LUO Quan and LI Changxing Department of Dermatology Guangzhou Institute of Dermatology Guangzhou China Department of Dermatology Shenzhen Dermatological Hospital Shenzhen China
    Chinese Medical Journal, 2006, (14) : 1230 - 1232
  • [32] The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum
    Hagman, JH
    Carrozzo, AM
    Campione, E
    Romanelli, P
    Chimenti, S
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2001, 12 (01) : 19 - 22
  • [33] Refractory steroid-resistant pyoderma gangrenosum successfully treated with intravenous immunoglobulins
    Kapetanovic, Igor
    Tanasilovic, Srdjan
    Lalosevic, Jovan
    Zivanovic, Dubravka
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [34] Successful Treatment of Pyoderma Gangrenosum with Intravenous Immunoglobulins during Pregnancy
    Erfurt-Berge, Cornelia
    Herbst, Christine
    Schuler, Gerold
    Bauerschmitz, Juergen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2012, 16 (03) : 205 - 207
  • [35] Hyperbaric oxygen therapy for refractory pyoderma gangrenosum: a salvage treatment
    Magalhaes, Rui de Sousa
    Moreira, Maria Joao
    Rosa, Bruno
    Cotter, Jose
    BMJ CASE REPORTS, 2021, 14 (02)
  • [36] Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
    Salehzadeh, Farhad
    Mohammadikebar, Yusef
    Enteshary, Afsaneh
    Ghanbarpour, Omid
    Mirzarahimi, Mehrdad
    BIOLOGICS-TARGETS & THERAPY, 2019, 13 : 97 - 99
  • [37] Ulcerative colitis with refractory pyoderma gangrenosum
    Liu, F. -C.
    Liu, N. -T.
    Huang, T. -Y.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (08) : 567 - 568
  • [38] Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 PatientsIntravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective AnalysisM. Ronicke et al.
    Moritz Ronicke
    Lukas Sollfrank
    Martin V. Vitus
    Lukas J. Walter
    Manuel Krieter
    Maurice Moelleken
    Joachim Dissemond
    Erwin Schultz
    Felix Lauffer
    Peter von den Driesch
    Cornelia Erfurt-Berge
    American Journal of Clinical Dermatology, 2025, 26 (1) : 139 - 146
  • [39] Refractory pyoderma gangrenosum in the retroauricular region
    Banham, E.
    Tritton, S. M.
    Jevtic, A.
    Watkins, F.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2011, 52 : 6 - 6
  • [40] Intravenous immunoglobulin is effective as a sole immunomodulatory agent in pyoderma gangrenosum unresponsive to systemic corticosteroids
    Suchak, R.
    Macedo, C.
    Glover, M.
    Lawlor, F.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) : 205 - 207
12345